,
Proven Outcomes in Cancer Imaging, Semin Nucl Med, vol.39, issue.4, pp.276-289 ,
Brain PET in the Diagnosis of Alzheimer's Disease, Clin Nucl Med, vol.39, issue.10, pp.423-426, 2014. ,
PET Imaging of the Neurovascular Interface in Cerebrovascular Disease, Nat Rev Neurol, vol.13, issue.11, pp.676-688, 2017. ,
Positive Progress in ImmunoPET-Not Just a Coincidence, Cancer Biotherapy & Radiopharmaceuticals, vol.25, issue.3, p.89, 2010. ,
, Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients, BioMed Research International, vol.2014, pp.1-13
Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET), Acc. Chem. Res, vol.42, issue.7, pp.832-841, 2009. ,
Copper 64-Labeled Daratumumab as a PET/CT Imaging Tracer for Multiple Myeloma, Blood, vol.131, issue.7, pp.741-745, 2018. ,
Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study, Journal of Nuclear Medicine, vol.53, issue.8, pp.1207-1215, 2012. ,
Head-to-Head Comparison of 64 Cu-DOTATATE and 68 Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors, Journal of Nuclear Medicine, vol.58, issue.3, pp.451-457, 2017. ,
,
2015) 64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients, Journal of Nuclear Medicine, vol.56, issue.12, pp.1895-1900 ,
Monopicolinate Cyclen and Cyclam Derivatives for Stable Copper(II) Complexation, Inorg. Chem, vol.51, issue.12, pp.6916-6927, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01557438
Radiolabeling of HTE1PA: A New Monopicolinate Cyclam Derivative for Cu-64 Phenotypic Imaging. In Vitro and in Vivo Stability Studies in Mice, Nucl Med Biol, pp.49-57, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01529578
Cyclam Te1pa for 64 Cu PET Imaging. Bioconjugation to Antibody, Radiolabeling and Preclinical Application in Xenografted Colorectal Cancer, vol.7, pp.9272-9283, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01463724
Synthesis of C-Functionalized TE1PA and Comparison with Its Analogues. An Example of Bioconjugation on 9E7.4 MAb for Multiple Myeloma 64Cu-PET Imaging, Org Biomol Chem, vol.16, issue.23, pp.4261-4271, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01804657
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 Is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model, Frontiers in Medicine, vol.2, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01817464
, Comparison of Immuno-PET of CD138 and PET Imaging with, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01677118
, CuCl 2 and 18 F-FDG in a Preclinical Syngeneic Model of Multiple Myeloma, Oncotarget, issue.10, p.9
, , 2000.
, In Vivo Transchelation of Copper-64 from TETA-Octreotide to
, Superoxide Dismutase in Rat Liver, Bioconjug Chem, vol.11, issue.4, pp.527-532
Comparison of DOTA and NODAGA as Chelators for (64)CuLabeled Immunoconjugates, Nucl. Med. Biol, vol.42, issue.2, pp.177-183, 2015. ,
Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA, Contrast Media Mol Imaging, p.8565802, 2017. ,
Synthesis of a New Cage Ligand, SarAr, and Its Complexation with Selected Transition Metal Ions for Potential Use in Radioimaging, Nature Protocols, vol.1, issue.15, pp.3062-3068, 2001. ,
Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes, J. Med. Chem, vol.47, issue.6, pp.1465-1474, 2004. ,
, , 1993.
Conjugates for Binding Copper in the Presence of Competing Metals, Inorg. Chem, vol.32, issue.19, pp.3981-3982 ,
Measurement of the Rate of Copper(II) Exchange for 64Cu Complexes of Bifunctional Chelators, Inorganica Chimica Acta, vol.393, pp.318-323, 2012. ,
Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study, J. Clin. Oncol, vol.35, issue.25, pp.2911-2918, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01726512
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging, World Journal of Gastroenterology, vol.5, issue.6, p.221, 2015. ,
Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules, Mol. Pharmaceutics, vol.13, issue.5, pp.1668-1678, 2016. ,
Theranostics of Malignant Melanoma with 64CuCl2, Journal of Nuclear Medicine, vol.55, issue.5, pp.812-817, 2014. ,
, Animal Model of Human Disease, 1988.
, The American Journal of Pathology, vol.132, issue.3, pp.593-597